BioSpace News Archive

The Boards of Directors of Washington Dental Service and Delta Dental of Washington (DDWA) today announced the appointment of Mark Mitchke, the veteran Amazon executive who led Amazon Global Fulfillment Services, as CEO of the two companies.

Every year, more than 44,900 people die by suicide in the United States, making suicide the 10th leading cause of death in this country. In an effort to raise funds and awareness for suicide prevention, Tony Nominated Actor Bryce Pinkham will be running the New York City Marathon on November 4, for the American Foundation for Suicide Prevention’s New York City Chapter.

CoreLink Surgical, LLC, today announced 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market the M3™ Stand-Alone Anterior Lumbar (ALIF) System.

The National Institute for Health and Education (NICHE) and Aurora Cannabis Inc. (“Aurora” or the “Company”) (TSX: ACB) (OTCQB: ACBFF) (Frankfurt: 21P; WKN: A1C4WM) are pleased to launch a new guide to cannabis legalization for municipal candidates, with a view to raising awareness of the new cannabis laws that will come into effect next month.

QuantuMDx Group Ltd, the UK-based multinational molecular diagnostics company, today announced two key leadership appointments. Dr Allan Brown has been appointed Chief Operating Officer and David Matthews joins as Chief Financial Officer.

21Medtech announced that Professor Matthew Becker, 21Medtech founder and inventor, has become the 20th recipient of the Carl S. Marvel Award in Creative Polymer Chemistry recognizing his accomplishments of unusual merit in the field of applied polymer science.

Synvitrobio, the leader in cell-free natural product discovery, announced the closure of an oversubscribed $2.6 million seed funding round, led by Social Capital, with participation from Fifty Years and KdT Ventures.

Theravance Biopharma, Inc. (NASDAQ: TBPH) (“Theravance Biopharma”) and Mylan N.V. (NASDAQ: MYL) (“Mylan”) today announced that new data from the Phase 3 YUPELRI™ (revefenacin) inhalation solution clinical program will be featured in an oral presentation at the European Respiratory Society (ERS) International Congress 2018, being held in Paris, France on September 15-19, 2018.

Blue Cross and Blue Shield of Minnesota launches campaign encouraging leaders to act on health inequities

Health Canada is informing Canadians that packages of certain lots of Marvelon 28 do not include day-of-the-week stickers.